Wednesday, September 5, 2018

Blood-Testing Firm Theranos to Dissolve

Wall Street Journal-8 hours ago

Theranos Inc., the blood-testing company accused of perpetrating Silicon Valley's biggest fraud, will soon cease to exist. In the wake of a high-profile scandal, ...

Blood-testing company Theranos will dissolve, pay creditors
USA TODAY-29 minutes ago

Blood-Testing Company Theranos to Dissolve After Fraud Scandal
Daily Beast-2 hours ago

Theranos is shutting down its fraudulent blood testing business
TNW-6 hours ago

Blood-testing group Theranos to dissolve following fraud scandal
Highly Cited-Financial Times-6 hours ago

Scandal-hit blood-testing firm Theranos bleeds out
In-Depth-The Australian-9 hours ago

Saturday, September 1, 2018

2018-2 ~ Louisiana Uniform Prescription Drug Prior Authorization Form [Source: Act 423 of 2018 Legislature]
               08-10-2018     1st Report submitted to Joint Legislative Oversight Committee on Health and Welfare.
               08-10-2018     Distributed electronic Notice of Rulemaking Activity to List of Interested Parties, as well as all pharmacies, pharmacists, pharmacy interns, pharmacy technicians, and pharmacy technician candidates.
               08-20-2018     Notice of Intent scheduled for publication in Louisiana Register.
               09-28-2018     Public Hearing - Alternative Location: La. State Board of Medical Examiners, located at 630 Camp St. in New Orleans, La. 70130

2018-K ~ Amends the PMP Law to grant access to state epidemiologists with Dept. of Health.
               02-07-2018 - Committee voted to recommend the approval of Draft #3 to the Board.
               02-21-2018 - Draft #3 approved for filing by the Board.
               02-26-2018 - Incorporated in SB 109; prefiled for 2018 Regular Session.
               08-01-2018 - Effective date of Act 232 (SB 109).

2018-J ~ Amends the pharmacist licensure requirements in the Pharmacy Practice Act.
               02-07-2018 - Committee voted to recommend the approval of Draft #1 to the Board.
               02-21-2018 - Draft #1 approved for filing by the Board.
               02-27-2018 - Incorporated in SB 131; prefiled for 2018 Regular Session.
               08-01-2018 - Effective date of Act 31 (SB 131).

2018-H ~ Amends the statutory definition of "drugs of concern" in the Prescription Monitoring Program (PMP) to facilitate the reporting of prescriptions for naloxone.
               02-07-2018 - Committee reviewed Draft #1 and requested a minor amendment, then voted to recommend the approval of Draft #2 to the Board.
               02-21-2018 - Draft #2 approved for filing by the Board.
               02-26-2018 - Incorporated in SB 110; prefiled for 2018 Regular Session.
               08-01-2018 - Effective date of Act 146 (SB 110).

September

Ohio State Board of Pharmacy Classifies Hemp-Derived CBD Oil as ...

https://www.hempbizjournal.com/ohio-pharmacy-board-reclassifies-cbd-oil/

3 days ago - The Ohio State Board of Pharmacy has issued a regulatory memo stating the CBD oil can only be ... Subscribe to the HBJ Newsletter | Published Every Sunday ...